Geoffrey A. Swire
Chief Operating Officer bij ALLENA PHARMACEUTICALS, INC.
Profiel
Geoffrey A.
Swire is currently the COO & Senior Vice President-Corporate Development at Allena Pharmaceuticals, Inc. He previously worked as the Head-Program & Portfolio Management at Genzyme Corp.
and as the Head-Business Development & Alliance Management at Radius Health, Inc. He completed his undergraduate degree at Dartmouth College and his graduate degree at Harvard University.
Actieve functies van Geoffrey A. Swire
| Bedrijven | Functie | Begin |
|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Chief Operating Officer | 10-11-2020 |
Eerdere bekende functies van Geoffrey A. Swire
| Bedrijven | Functie | Einde |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| RADIUS HEALTH, INC. | Corporate Officer/Principal | - |
Opleiding van Geoffrey A. Swire
| Dartmouth College | Undergraduate Degree |
| Harvard University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
